BR112020019761A2 - formulação de goma oral e processo de fabricação da mesma - Google Patents

formulação de goma oral e processo de fabricação da mesma Download PDF

Info

Publication number
BR112020019761A2
BR112020019761A2 BR112020019761-0A BR112020019761A BR112020019761A2 BR 112020019761 A2 BR112020019761 A2 BR 112020019761A2 BR 112020019761 A BR112020019761 A BR 112020019761A BR 112020019761 A2 BR112020019761 A2 BR 112020019761A2
Authority
BR
Brazil
Prior art keywords
weight
ratio
water
formulation
sorbitol
Prior art date
Application number
BR112020019761-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Régine Detalle
Olivier Piar
Laurent Slipecki
Perline Pourantru
Catherine Blandin
Aïcha Chekkal
Elodie Lalouer
Original Assignee
Sanofi Winthrop Industrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Winthrop Industrie filed Critical Sanofi Winthrop Industrie
Publication of BR112020019761A2 publication Critical patent/BR112020019761A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR112020019761-0A 2018-04-03 2019-03-29 formulação de goma oral e processo de fabricação da mesma BR112020019761A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18305393.3 2018-04-03
EP18305393.3A EP3549579A1 (en) 2018-04-03 2018-04-03 Oral gum formulation and fabrication process thereof
PCT/EP2019/058109 WO2019192942A1 (en) 2018-04-03 2019-03-29 Oral gum formulation and fabrication process thereof

Publications (1)

Publication Number Publication Date
BR112020019761A2 true BR112020019761A2 (pt) 2021-01-26

Family

ID=61965891

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112020019761-0A BR112020019761A2 (pt) 2018-04-03 2019-03-29 formulação de goma oral e processo de fabricação da mesma

Country Status (7)

Country Link
US (1) US20210093562A1 (https=)
EP (2) EP3549579A1 (https=)
JP (1) JP2021520408A (https=)
BR (1) BR112020019761A2 (https=)
MX (1) MX2020010400A (https=)
RU (1) RU2020135965A (https=)
WO (1) WO2019192942A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3826471A4 (en) * 2018-07-26 2022-05-04 Wm. Wrigley Jr. Company METHOD OF REDUCING CURING TIME FOR SEALED CONFECTIONERY PRODUCTS
WO2022119965A1 (en) * 2020-12-01 2022-06-09 Seattle Gummy Company Antihistamine semi-solid chewable gel compositions and methods of making and using thereof
US20250066092A1 (en) * 2023-08-25 2025-02-27 Day Dreamers Confections Direct-Mold Blister Packaging System for Chocolate and Gummy Products

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897566A (en) * 1973-12-06 1975-07-29 Gen Foods Corp Chewing gums having longer lasting sweetness and flavor
US4780324A (en) * 1987-06-23 1988-10-25 Warner-Lambert Company Chewing gum with long lasting softness
US4804543A (en) * 1987-07-14 1989-02-14 Warner-Lambert Company Novel hydrophilic plasticizing system and chewing gum containing same
US6451815B1 (en) 1997-08-14 2002-09-17 Aventis Pharmaceuticals Inc. Method of enhancing bioavailability of fexofenadine and its derivatives
US6235318B1 (en) * 1999-01-21 2001-05-22 Charles M. Lombardy, Jr. Effervescent chewing gum
US20100136164A1 (en) * 2004-08-25 2010-06-03 Cadbury Adams Usa Llc Package assembly for multi-modality taste chewing gum compositions
CA2578258C (en) * 2004-08-25 2012-11-13 Cadbury Adams Usa Llc Liquid-filled chewing gum composition
JP2009159843A (ja) * 2007-12-28 2009-07-23 Uha Mikakuto Co Ltd チューインガムとその製造方法
CN101628117B (zh) * 2009-08-18 2011-02-16 北京航洋胶囊技术有限公司 一种咀嚼软胶囊皮、咀嚼软胶囊药物及其制备方法
KR20150116861A (ko) 2013-02-14 2015-10-16 사노피 경구 투여용 츄어블 조성물 및 그의 제조 방법
CA2864531A1 (en) * 2014-02-06 2015-08-06 RAP Nutrition LLC High protein gummy product and process of making
US20160067180A1 (en) 2014-09-05 2016-03-10 Santa Cruz Pharmaceuticals, Inc. Semi-solid chewable dosage form for over-the-counter medications and method for producing same
US9867779B2 (en) * 2015-03-26 2018-01-16 Patheon Softgels Inc. Liquisoft capsules
US9833408B1 (en) * 2016-07-28 2017-12-05 Allen Greenspoon Orally administrable formulation

Also Published As

Publication number Publication date
EP3549579A1 (en) 2019-10-09
RU2020135965A (ru) 2022-05-04
JP2021520408A (ja) 2021-08-19
MX2020010400A (es) 2021-02-09
EP3773470A1 (en) 2021-02-17
US20210093562A1 (en) 2021-04-01
WO2019192942A1 (en) 2019-10-10

Similar Documents

Publication Publication Date Title
US12296043B2 (en) Liquisoft capsules
TWI405592B (zh) 非明膠軟膠囊系統
Ubhe et al. A brief overview on tablet and it’s types
ES2612032T3 (es) Formas farmacéuticas orales basadas en lípidos inviolables para agonistas opiáceos
Nagaraju et al. Comprehensive review on oral disintegrating films
ES2302926T5 (es) Cápsula blanda masticable
EP3154529B1 (en) Orally disintegrating tablet containing solid lipid particles and methods for their preparation and use
JP2004534839A (ja) 連続的薬剤送達システム
EP2827839B1 (en) Gelling agent-based dosage form
JPWO2006070578A1 (ja) 硬カプセルのバンドシール
BR112020019761A2 (pt) formulação de goma oral e processo de fabricação da mesma
JP2009521433A (ja) 低粘度アルギン酸塩含有水溶性薄膜
CN102172345A (zh) 用于调配包含至少一种基于分子量选择的鱼明胶的快速分散剂型的方法
US20060165795A1 (en) Medicinal compositions comprising a core and a film based on modified cellulose derivatives
US7780977B2 (en) Medication compositions
BRPI0715756B1 (pt) Composição farmacêutica para administração oral, seus usos, e medicamento
ES2351067T3 (es) Composiciones farmacéuticas fáciles de tragar, que no provocan una sensación desagradable en la boca y que comprenden partículas con un ingrediente activo.
CA2623306C (en) Oral vehicle for systemic pharmaceuticals
US20180318228A1 (en) Method for a slow release of drugs from orally dissolving capsules
Al-Achi et al. Suppository preparation: Density factor determination for some over-the-counter analgesic products

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2768 DE 23-01-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.